Human Leukocyte Interferon and Cimetidine for Metastatic Melanoma
Authors:
- S BorgströmSBS Borgström
- F E Von EybenFEF E Von Eyben
- P FlodgrenPFP Flodgren
- B AxelssonBAB Axelsson
- H O SjögrenHSH O Sjögren
- 21 October 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 307 (17) , 1080-1081
Abstract
To the Editor: The use of interferon in the treatment of metastatic malignant melanoma has met with limited success.1 , 2 This may be due to interferon-induced activation of suppressor cells3 — T cells bearing histamine2 receptors. We have initiated a study to investigate whether the therapeutic efficacy of interferon could be enhanced by complementary treatment with cimetidine, a histamine2 antagonist. We wish to communicate our encouraging results in treating six consecutive patients, all of whom had microscopically verified, measurable, recurrent melanoma. Treatment was started with 4X106 to 12X106 units of leukocyte interferon4 (A/S Alfred Benson, Copenhagen, Denmark) given . . .Keywords
This publication has 5 references indexed in Scilit:
- Autologous mixed lymphocyte reaction in man. II. Histamine-induced suppression of the autologous mixed lymphocyte reaction by T-cell subsets defined with monoclonal antibodiesJournal of Clinical Immunology, 1981
- SUCCESSFUL TUMOUR IMMUNOTHERAPY WITH CIMETIDINE IN MICEThe Lancet, 1981
- CIMETIDINE REDUCTION OF TUMOUR FORMATION IN MICEThe Lancet, 1981
- Interferon immunosuppression: mediation by a suppressor factorInfection and Immunity, 1980
- ANTITUMOUR EFFECT OF CIMETIDINE?The Lancet, 1979